WASHINGTON AP – Cardinal Health Inc. will pay $34 million to settle claims that it failed to report suspicious sales of controlled substances, the Department of Justice said on Thursday.

Cardinal, one of the nation’s largest distributors of pharmaceutical drugs, reached an agreement with seven U.S. Attorney’s Offices and the Drug Enforcement Agency to pay $34 million in civil penalties for alleged violations of its obligations under the Controlled Substances Act.